Annual Retained Earnings
$503.02 M
+$52.15 M+11.57%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual retained earnings is currently $503.02 million, with the most recent change of +$52.15 million (+11.57%) on 31 December 2023. During the last 3 years, it has risen by +$111.06 million (+28.34%). LGND annual retained earnings is now at all-time high.LGND Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$530.07 M
-$7.17 M-1.33%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly retained earnings is currently $530.07 million, with the most recent change of -$7.17 million (-1.33%) on 30 September 2024. Over the past year, it has increased by +$45.24 million (+9.33%). LGND quarterly retained earnings is now -10.03% below its all-time high of $589.15 million, reached on 31 March 2024.LGND Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.6% | +9.3% |
| 3 y3 years | +28.3% | +16.6% |
| 5 y5 years | +319.5% | +30.1% |
LGND Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +28.3% | -10.0% | +18.0% |
| 5 y | 5 years | at high | +319.5% | -10.0% | +43.0% |
| alltime | all time | at high | +158.3% | -10.0% | +152.8% |
Ligand Pharmaceuticals Incorporated Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $530.07 M(-1.3%) |
| June 2024 | - | $537.24 M(-8.8%) |
| Mar 2024 | - | $589.15 M(+17.1%) |
| Dec 2023 | $503.02 M(+11.6%) | $503.02 M(+3.8%) |
| Sept 2023 | - | $484.83 M(-2.1%) |
| June 2023 | - | $495.10 M(+0.5%) |
| Mar 2023 | - | $492.81 M(+9.3%) |
| Dec 2022 | $450.86 M(+0.4%) | $450.86 M(-3.7%) |
| Sept 2022 | - | $468.35 M(+0.1%) |
| June 2022 | - | $467.94 M(-0.2%) |
| Mar 2022 | - | $468.84 M(+4.4%) |
| Dec 2021 | $449.09 M(+14.6%) | $449.09 M(-1.2%) |
| Sept 2021 | - | $454.51 M(+3.1%) |
| June 2021 | - | $440.78 M(+7.5%) |
| Mar 2021 | - | $410.06 M(+4.6%) |
| Dec 2020 | $391.95 M(-2.0%) | $391.95 M(+1.5%) |
| Sept 2020 | - | $386.19 M(-1.7%) |
| June 2020 | - | $392.89 M(+6.0%) |
| Mar 2020 | - | $370.81 M(-7.3%) |
| Dec 2019 | $400.11 M(-274.6%) | $400.11 M(-1.8%) |
| Sept 2019 | - | $407.47 M(-3.6%) |
| June 2019 | - | $422.72 M(-3.3%) |
| Mar 2019 | - | $437.14 M(-290.7%) |
| Dec 2018 | -$229.20 M(-42.8%) | -$229.20 M(+24.6%) |
| Sept 2018 | - | -$183.91 M(-27.7%) |
| June 2018 | - | -$254.24 M(-22.3%) |
| Mar 2018 | - | -$327.40 M(-18.3%) |
| Dec 2017 | -$400.92 M(-7.0%) | -$400.92 M(+1.8%) |
| Sept 2017 | - | -$393.91 M(-2.1%) |
| June 2017 | - | -$402.34 M(-1.5%) |
| Mar 2017 | - | -$408.40 M(-5.3%) |
| Dec 2016 | -$431.13 M(+0.4%) | -$431.13 M(+0.7%) |
| Sept 2016 | - | -$428.00 M(+6.7%) |
| June 2016 | - | -$401.17 M(+1.5%) |
| Mar 2016 | - | -$395.40 M(-7.9%) |
| Dec 2015 | -$429.49 M(-34.9%) | -$429.49 M(+4.6%) |
| Sept 2015 | - | -$410.46 M(-35.4%) |
| June 2015 | - | -$635.00 M(-3.6%) |
| Mar 2015 | - | -$658.56 M(-0.1%) |
| Dec 2014 | -$659.32 M(-1.8%) | -$659.32 M(-1.1%) |
| Sept 2014 | - | -$666.37 M(-0.2%) |
| June 2014 | - | -$667.65 M(-0.2%) |
| Mar 2014 | - | -$669.24 M(-0.3%) |
| Dec 2013 | -$671.34 M(-1.7%) | -$671.34 M(-0.3%) |
| Sept 2013 | - | -$673.21 M(-0.3%) |
| June 2013 | - | -$675.17 M(-0.9%) |
| Mar 2013 | - | -$681.26 M(-0.2%) |
| Dec 2012 | -$682.76 M(+0.1%) | -$682.76 M(-0.2%) |
| Sept 2012 | - | -$683.82 M(+0.2%) |
| June 2012 | - | -$682.65 M(+0.3%) |
| Mar 2012 | - | -$680.39 M(-0.3%) |
| Dec 2011 | -$682.23 M(-1.4%) | -$682.23 M(-0.7%) |
| Sept 2011 | - | -$687.27 M(+0.6%) |
| June 2011 | - | -$683.38 M(+0.1%) |
| Mar 2011 | - | -$682.46 M(-1.4%) |
| Dec 2010 | -$691.95 M(+1.5%) | -$691.95 M(-0.6%) |
| Sept 2010 | - | -$696.45 M(+1.7%) |
| June 2010 | - | -$684.61 M(+0.0%) |
| Mar 2010 | - | -$684.33 M(+0.4%) |
| Dec 2009 | -$681.57 M | -$681.57 M(-0.4%) |
| Sept 2009 | - | -$684.58 M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | -$686.39 M(+0.2%) |
| Mar 2009 | - | -$684.72 M(+0.7%) |
| Dec 2008 | -$679.63 M(+16.9%) | -$679.63 M(+11.4%) |
| Sept 2008 | - | -$610.00 M(+3.1%) |
| June 2008 | - | -$591.87 M(+1.1%) |
| Mar 2008 | - | -$585.45 M(+0.7%) |
| Dec 2007 | -$581.51 M(-32.6%) | -$581.51 M(-1.0%) |
| Sept 2007 | - | -$587.45 M(-0.2%) |
| June 2007 | - | -$588.70 M(-0.0%) |
| Mar 2007 | - | -$588.88 M(-31.7%) |
| Dec 2006 | -$862.80 M(+3.8%) | -$862.80 M(-14.1%) |
| Sept 2006 | - | -$1.00 B(+1.5%) |
| June 2006 | - | -$989.25 M(+1.6%) |
| Mar 2006 | - | -$973.29 M(+17.1%) |
| Dec 2005 | -$831.06 M(+4.6%) | -$831.06 M(+0.3%) |
| Sept 2005 | - | -$828.34 M(+0.8%) |
| June 2005 | - | -$822.06 M(+1.1%) |
| Mar 2005 | - | -$813.13 M(+2.3%) |
| Dec 2004 | -$794.66 M(+6.0%) | -$794.66 M(+15.2%) |
| Sept 2004 | - | -$689.92 M(+1.0%) |
| June 2004 | - | -$683.13 M(+2.1%) |
| Mar 2004 | - | -$668.92 M(-10.8%) |
| Dec 2003 | -$749.52 M(+21.2%) | -$749.52 M(+13.3%) |
| Sept 2003 | - | -$661.72 M(+1.7%) |
| June 2003 | - | -$650.63 M(+1.9%) |
| Mar 2003 | - | -$638.64 M(+3.3%) |
| Dec 2002 | -$618.32 M(+5.6%) | -$618.32 M(+1.1%) |
| Sept 2002 | - | -$611.59 M(+1.2%) |
| June 2002 | - | -$604.54 M(+2.1%) |
| Mar 2002 | - | -$592.29 M(+1.1%) |
| Dec 2001 | -$585.72 M(+7.9%) | -$585.72 M(+2.3%) |
| Sept 2001 | - | -$572.66 M(+1.4%) |
| June 2001 | - | -$564.92 M(+1.9%) |
| Mar 2001 | - | -$554.31 M(+2.1%) |
| Dec 2000 | -$542.73 M(+15.4%) | -$542.73 M(+5.0%) |
| Sept 2000 | - | -$516.69 M(+3.0%) |
| June 2000 | - | -$501.76 M(+3.4%) |
| Mar 2000 | - | -$485.30 M(+3.2%) |
| Dec 1999 | -$470.30 M(+18.9%) | -$470.30 M(+5.1%) |
| Sept 1999 | - | -$447.50 M(+4.3%) |
| June 1999 | - | -$429.20 M(+4.6%) |
| Mar 1999 | - | -$410.20 M(+3.7%) |
| Dec 1998 | -$395.60 M(+42.5%) | -$395.60 M(+11.4%) |
| Sept 1998 | - | -$355.00 M(+15.0%) |
| June 1998 | - | -$308.70 M(+6.0%) |
| Mar 1998 | - | -$291.30 M(+4.9%) |
| Dec 1997 | -$277.70 M(+56.4%) | -$277.70 M(+32.4%) |
| Sept 1997 | - | -$209.70 M(+5.9%) |
| June 1997 | - | -$198.10 M(+5.5%) |
| Mar 1997 | - | -$187.70 M(+5.7%) |
| Dec 1996 | -$177.60 M(+26.6%) | -$177.60 M(+7.1%) |
| Sept 1996 | - | -$165.80 M(+5.3%) |
| June 1996 | - | -$157.40 M(+6.8%) |
| Mar 1996 | - | -$147.40 M(+5.1%) |
| Dec 1995 | -$140.30 M(+84.4%) | -$140.30 M(+6.4%) |
| Sept 1995 | - | -$131.90 M(+61.1%) |
| Mar 1995 | - | -$81.90 M(+7.6%) |
| Dec 1994 | -$76.10 M | -$76.10 M(+9.3%) |
| Sept 1994 | - | -$69.60 M(+10.0%) |
| June 1994 | - | -$63.30 M(+13.0%) |
| Mar 1994 | - | -$56.00 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual retained earnings?
- What is the all time high annual retained earnings for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual retained earnings year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly retained earnings?
- What is the all time high quarterly retained earnings for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual retained earnings?
The current annual retained earnings of LGND is $503.02 M
What is the all time high annual retained earnings for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual retained earnings is $503.02 M
What is Ligand Pharmaceuticals Incorporated annual retained earnings year-on-year change?
Over the past year, LGND annual retained earnings has changed by +$52.15 M (+11.57%)
What is Ligand Pharmaceuticals Incorporated quarterly retained earnings?
The current quarterly retained earnings of LGND is $530.07 M
What is the all time high quarterly retained earnings for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly retained earnings is $589.15 M
What is Ligand Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
Over the past year, LGND quarterly retained earnings has changed by +$45.24 M (+9.33%)